MYOM2 and Miyoshi myopathy: SMM fulfills the diagnostic criteria for MM, with serum M-protein ≥30 g/L and/or bone marrow clonal plasma cells ≥10% however without clinical CRAB symptoms or end organ damage that dictate therapeutic intervention.